Week Ending February 22, 2022

Modest Association Between Chronic Hepatitis C Virus Infection and Esophageal Cancer
“A modest association appears to exist between chronic hepatitis C virus (HCV) infection and incidence of esophageal cancer, according to a systematic review and meta-analysis published in the Journal of Clinical Gastroenterology.”

Revealed an enzyme of the white mushroom that acts against hepatitis C
“A team of researchers from the Higher Council for Scientific Research (CSIC) has co-discovered that an enzyme present in white mushrooms (Agaricus bisporus), called tyrosinase, has It has antiviral activity against the hepatitis C virus through an inhibition mechanism different from that of the usual drugs.”

Discovery may lead to new treatment approach for people with alcohol-associated liver disease
“Investigators at Cedars-Sinai have uncovered a new pathway that helps explain how consuming too much alcohol causes damage to the liver, specifically mitochondrial dysfunction in alcohol-associated liver disease.”

Florida Health System Uses AI to Predict Hepatitis C Treatment Outcomes
“University of Florida Health researchers have developed algorithms using artificial intelligence to accurately predict hepatitis C treatment outcomes. The algorithms use machine learning to produce treatment-failure predictions that are more accurate than current statistical models, according to a new study.”

H1-Antihistamine Use and Risk of Hepatocellular Carcinoma in Persons With Hepatitis B Virus, Hepatitis C Virus, or Dual Infection
“In a Taiwanese study reported in the Journal of Clinical Oncology, Shen et al found that use of H1-antihistamines was associated with reduced risk of hepatocellular carcinoma in patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or dual HBV/HCV infection.”

Universal HCV Screening in Pregnancy Boosts Detection
“If you want to find undiagnosed hepatitis C virus (HCV) infection in mothers-to-be, a universal testing program for the disease among all pregnant individuals is the way to go, a researcher reported.”

Long-Term Opioid Use Increases Risk for Hepatitis C Virus Seroconversion
“For individuals with a long-term opioid prescription for noncancer pain, risk for hepatitis C virus (HCV) acquisition was increased, suggesting that initiation of intravenous drug use may be correlated. These findings were published in JAMA Network Open.”

Treatment with direct-acting antivirals improves outcomes for hepatitis C patients
“Direct-acting antiviral medicines (DAAs) show great promise as a way of improving the overall health of patients with chronic hepatitis C, according to results of a recent study.”